APA (7th ed.) Citation

S, A., A, I., S, N., M, J., V, M., S, T., . . . O, A. (2026). EGFR-targeted tyrosine kinase inhibitors: Advancements in cancer therapy. Naunyn-Schmiedeberg's archives of pharmacology, 399(4), 4737. https://doi.org/10.1007/s00210-025-04596-9

Chicago Style (17th ed.) Citation

S, Ali, Ilyas A, Nazar S, Jha M, Mathur V, Tanweer S, Grover S, and Alam O. "EGFR-targeted Tyrosine Kinase Inhibitors: Advancements in Cancer Therapy." Naunyn-Schmiedeberg's Archives of Pharmacology 399, no. 4 (2026): 4737. https://doi.org/10.1007/s00210-025-04596-9.

MLA (9th ed.) Citation

S, Ali, et al. "EGFR-targeted Tyrosine Kinase Inhibitors: Advancements in Cancer Therapy." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 399, no. 4, 2026, p. 4737, https://doi.org/10.1007/s00210-025-04596-9.